BDBM742442 4-methyl-1-[2-(4- methylsulfonyl- piperazin-1- yl)propyl]-5- [[2-[6-(2,2,2- trifluoroethyl)pyrido [3,4-d]pyrimidin-4-yl]- 2,7-diazaspiro[3.5] nonan-7-yl] methyl]indole- 2-carbonitrile Example 34::US20250163061, Compound 45

SMILES Cc1c(CN2CCC3(CC2)CN(c2ncnc4cnc(CC(F)(F)F)cc24)C3)ccc2c1cc(C#N)n2CC(C)N1CCN(S(C)(=O)=O)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742442   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742442(4-methyl-1-[2-(4- methylsulfonyl- piperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent